M. Davies

M. Mendelson, T. Boyles, M. Davies, 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.

D. Raben, F. Tanser, C. Chimbetete, 2016, International journal of epidemiology.

Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration

O. Keiser, M. Davies, N. Maxwell, 2016, PloS one.

Outcomes of antiretroviral treatment programmes in rural Lesotho: health centres and hospitals compared

M. Egger, G. Wandeler, O. Keiser, 2013, Journal of the International AIDS Society.

CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa.

Richard D Moore, E. Vittinghoff, C. Yiannoutsos, 2015, International journal of epidemiology.

Antibiotic use and resistance: Knowledge, attitudes and perceptions among primary care prescribers in South Africa.

T. Boyles, M. Davies, A. Stewart, 2018, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

The cascade of care to prevent mother‐to‐child transmission in Rio de Janeiro, Brazil, 1996–2013: improving but still some way to go

M. Egger, O. Keiser, M. Davies, 2017, Tropical medicine & international health : TM & IH.

Assessing the risk of dolutegravir for women of childbearing potential.

N. Ford, M. Davies, M. Cornell, 2018, The Lancet. Global health.

Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network

M. Yotebieng, M. Lindegren, A. Mandalakas, 2017, Journal of acquired immune deficiency syndromes.

Low rates of hepatotoxicity in HIV-infected children on anti-retroviral therapy with and without isoniazid prophylaxis.

H. Zar, B. Eley, M. Cotton, 2010, Journal of tropical pediatrics.

Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.

B. Chi, J. Stringer, M. Vinikoor, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tenofovir stock shortages have limited impact on clinic‐ and patient‐level HIV treatment outcomes in public sector clinics in South Africa

M. Davies, M. Fox, I. Sanne, 2017, Tropical medicine & international health : TM & IH.

Mortality and losses to follow‐up among adolescents living with HIV in the IeDEA global cohort collaboration

M. Yotebieng, S. Ayaya, K. Wools-Kaloustian, 2018, Journal of the International AIDS Society.

The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Failure Time Definition and CD4 Count at Failure.

F. Tanser, R. Wood, M. Davies, 2020, American journal of epidemiology.

Neonatal and infant diagnostic HIV‐PCR uptake and associations during three sequential policy periods in Cape Town, South Africa: a longitudinal analysis

M. Davies, A. Boulle, M. Osler, 2018, Journal of the International AIDS Society.

The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure

M. Egger, B. Eley, R. Wood, 2012, Tropical medicine & international health : TM & IH.

Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy – The IeDEA Southern Africa Collaboration

M. Egger, B. Eley, R. Wood, 2011, Tropical medicine & international health : TM & IH.

HIV-associated malignancies in children

J. Bohlius, M. Davies, G. Naidu, 2017, Current opinion in HIV and AIDS.

Outcomes of second‐line antiretroviral therapy among children living with HIV: a global cohort analysis

M. Yotebieng, C. Giaquinto, L. Mofenson, 2020, Journal of the International AIDS Society.

COVID-19 in-hospital mortality in South Africa: the intersection of communicable and non-communicable chronic diseases in a high HIV prevalence setting

M. Davies, L. Blumberg, L. Blumberg, 2020, medRxiv.

Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia

B. Chi, M. Egger, M. Saag, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Age- and sex-specific weight gain norms to monitor antiretroviral treatment in children in low- and middle-income countries

M. Yotebieng, F. Behets, O. Keiser, 2015 .

Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies

M. Egger, O. Keiser, M. Davies, 2009, African journal of AIDS research : AJAR.

Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs.

G. Meintjes, M. Davies, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study

J. Stringer, M. Egger, T. Hallett, 2013, PloS one.

Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay

H. Zar, S. Pienaar, R. Wilkinson, 2009, AIDS.

Comparison of T-SPOT.TB Assay and Tuberculin Skin Test for the Evaluation of Young Children at High Risk for Tuberculosis in a Community Setting

R. Wilkinson, B. Eley, M. Hatherill, 2009, Pediatrics.

Monitoring and Switching of First-line Antiretroviral Therapy in sub-Saharan Africa: Collaborative Analysis of Adult Treatment Cohorts

M. Egger, F. Dabis, G. Wandeler, 2015 .

Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests

T. de Oliveira, J. Bhiman, C. Williamson, 2021, Journal of Virological Methods.

Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis

R. Wilkinson, C. Williamson, W. Preiser, 2022, International Journal of Infectious Diseases.

Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa

J. Bhiman, C. Scheepers, R. Parboosing, 2021, medRxiv.

Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy

R. Wilkinson, C. Williamson, W. Preiser, 2021, medRxiv.

The Contribution of Maternal HIV Seroconversion During Late Pregnancy and Breastfeeding to Mother-to-Child Transmission of HIV

M. Newell, M. Davies, R. Bland, 2012, Journal of acquired immune deficiency syndromes.

Outcomes of laboratory‐confirmed SARS‐CoV‐2 infection in the Omicron‐driven fourth wave compared with previous waves in the Western Cape Province, South Africa

M. Mendelson, H. Mahomed, R. Kassanjee, 2022, medRxiv.

Detection of a SARS-CoV-2 variant of concern in South Africa

Sergei L. Kosakovsky Pond, A. Godzik, A. Sigal, 2021, Nature.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Antimicrobial stewardship in the Western Cape: A situational analysis of existing facility-level initiatives.

J. L. Werner, M. Davies, B. Willems, 2021, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Early Mortality and Loss to Follow-up in HIV-Infected Children Starting Antiretroviral Therapy in Southern Africa

M. Egger, B. Eley, R. Wood, 2010, Journal of acquired immune deficiency syndromes.

Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa

M. Mendelson, R. Wilkinson, H. Mahomed, 2022, International Journal of Infectious Diseases.

C. Williamson, W. Preiser, M. Davies, 2022, medRxiv.

Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study

Christine S. Smedley, L. Zühlke, J. Bhiman, 2021, The Lancet Global Health.

Increased mortality among individuals hospitalised with COVID-19 during the second wave in South Africa

J. Bhiman, M. Davies, L. Blumberg, 2021, medRxiv.

Temporal Trends in the Characteristics of Children at Antiretroviral Therapy Initiation in Southern Africa: The IeDEA-SA Collaboration

M. Egger, B. Eley, R. Wood, 2013, PloS one.

Virologic Failure and Second-Line Antiretroviral Therapy in Children in South Africa—The IeDEA Southern Africa Collaboration

M. Egger, B. Eley, R. Wood, 2011, Journal of acquired immune deficiency syndromes.

Adolescent retention in HIV care within differentiated service-delivery models in sub-Saharan Africa.

M. Davies, M. Fox, M. Maskew, 2022, The lancet. HIV.

International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012–2019

C. H. Dao Ostinelli, K. Anastos, M. Egger, 2020, BMJ Open.

Trends in CD4 and viral load testing 2005 to 2018: multi‐cohort study of people living with HIV in Southern Africa

C. H. Dao Ostinelli, N. Ford, M. Egger, 2020, Journal of the International AIDS Society.

Trends in CD4 and viral load testing 2005 to 2018: Multi-cohort study of people living with HIV in Southern Africa

N. Ford, M. Egger, F. Tanser, 2020 .

Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries

J. Etard, M. Davies, S. Wanjala, 2018, PloS one.

Targeting 90–90–90 – don't leave children and adolescents behind

M. Davies, J. Pinto, 2015, Journal of the International AIDS Society.

Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa

J. Bhiman, C. Scheepers, R. Parboosing, 2022, Nature Communications.

Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa

M. Egger, R. Wood, D. Dickinson, 2013, AIDS.

Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared with HIV-unexposed

L. Myer, B. Eley, M. Cotton, 2021, AIDS.

Preterm birth and severe morbidity in hospitalized neonates who are HIV exposed and uninfected compared with HIV unexposed

L. Myer, B. Eley, M. Harrison, 2021, AIDS.

Title: Impact of antiretroviral therapy on liver fibrosis among HIV-infected adults with and without HBV coinfection in Zambia

Zude, B. Chi, M. Egger, 2017 .

Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1–5 Years: A Causal Modeling Analysis

M. Egger, F. Tanser, R. Wood, 2015, Epidemiology.

A Causal Modeling Analysis

M. Egger, F. Tanser, R. Wood, 2022 .

A tale of two variants: Spread of SARS-CoV-2 variants Alpha in Geneva, Switzerland, and Beta in South Africa

C. Althaus, R. Neher, E. Hodcroft, 2021, medRxiv.

Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries.

N. Ford, C. Yiannoutsos, K. Anastos, 2021, The lancet. HIV.

Short-term outcomes of down-referral in provision of paediatric antiretroviral therapy at Red Cross War Memorial Children's Hospital, Cape Town, South Africa: A retrospective cohort study.

B. Eley, M. Davies, J. Copelyn, 2018, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy.

B. Eley, G. Hussey, M. Davies, 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa.

M. Davies, 2020, medRxiv : the preprint server for health sciences.

Retention in Care of HIV-Infected Children from HIV Test to Start of Antiretroviral Therapy: Systematic Review

M. Egger, G. Wandeler, N. Bender, 2013, PloS one.

Treatment outcomes in perinatally infected HIV-positive adolescents and young adults after ≥10 years on antiretroviral therapy.

M. Davies, R. Muloiwa, K. Anderson, 2018, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy—Results From the IeDEA Collaboration

Richard D Moore, B. Eley, M. Law, 2017, Journal of acquired immune deficiency syndromes.

Outcomes of Antiretroviral Therapy in Children in Asia and Africa: A Comparative Analysis of the IeDEA Pediatric Multiregional Collaboration

C. Yiannoutsos, S. Ayaya, L. Mofenson, 2013, Journal of acquired immune deficiency syndromes.

Prospects for HIV control in South Africa: a model-based analysis.

L. Myer, L. Bekker, M. Davies, 2016, Global health action.

Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study

B. Eley, M. Davies, A. Boulle, 2008, BMC pediatrics.

Research gaps in neonatal HIV-related care

M. Davies, 2015, Southern African journal of HIV medicine.

Where do HIV-infected adolescents go after transfer? – Tracking transition/transfer of HIV-infected adolescents using linkage of cohort data to a health information system platform

B. Eley, R. Wood, N. Tiffin, 2017, Journal of the International AIDS Society.

Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa

L. Myer, M. Davies, A. Boulle, 2020, BMC Pregnancy and Childbirth.

Steep Declines in Pediatric AIDS Mortality in South Africa, Despite Poor Progress Toward Pediatric Diagnosis and Treatment Targets

M. Davies, M. Maskew, L. Johnson, 2020, The Pediatric infectious disease journal.

Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?

C. Yiannoutsos, F. Tanser, K. Wools-Kaloustian, 2017, AIDS.

Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale

M. Yotebieng, S. Olsson, P. Braitstein, 2016, Drug Safety.

Viral load versus CD4+ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study

M. Egger, B. Eley, R. Wood, 2014, AIDS.

Cohort profile: the Western Cape Pregnancy Exposure Registry (WCPER)

L. Myer, K. Fieggen, C. Stewart, 2022, BMJ Open.

Transition from paediatric to adult care of adolescents living with HIV in sub-Saharan Africa: challenges, youth-friendly models, and outcomes

M. Yotebieng, S. Ayaya, M. Davies, 2017, Journal of the International AIDS Society.

Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia

L. Myer, M. Vinikoor, M. Davies, 2022, BMC Public Health.

Safety and Effectiveness of Isoniazid Preventive Therapy in Pregnant Women Living with Human Immunodeficiency Virus on Antiretroviral Therapy: An Observational Study Using Linked Population Data

L. Myer, G. Maartens, M. Davies, 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Antiretroviral treatment for children.

B. Eley, H. Finlayson, M. Davies, 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

The Effect of Early Initiation of Antiretroviral Treatment in Infants on Pediatric AIDS Mortality in South Africa: A Model-based Analysis

M. Newell, M. Davies, R. Bland, 2012, The Pediatric infectious disease journal.

The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Deﬁnition of Failure Time and CD4 Count at Failure

F. Tanser, R. Wood, M. Davies, 2020 .

Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model‐based analysis to inform paediatric HIV screening programmes

K. Freedberg, A. Ciaranello, M. Davies, 2022, Journal of the International AIDS Society.

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

A. Diacon, H. Mahomed, N. Garrett, 2022, The Lancet.

Association between hepatitis B co‐infection and elevated liver stiffness among HIV‐infected adults in Lusaka, Zambia

B. Chi, M. Egger, R. Chilengi, 2016, Tropical medicine & international health : TM & IH.

Life expectancy trends in adults on antiretroviral treatment in South Africa

F. Tanser, O. Keiser, M. Davies, 2016, AIDS.

Hard choices: Ethical challenges in phase 1 of COVID-19 vaccine roll-out in South Africa.

L. London, M. Davies, M. Blockman, 2021, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Long-term outcomes in perinatally HIV-infected adolescents and young adults on antiretroviral therapy: a review of South African and global literature

M. Davies, R. Muloiwa, K. Anderson, 2020, African journal of AIDS research : AJAR.

Survival and health of children who are HIV-exposed uninfected: study protocol for the CHERISH (Children HIV-Exposed Uninfected - Research to Inform Survival and Health) dynamic, prospective, maternal-child cohort study

L. Myer, M. Cotton, M. Tomlinson, 2023, BMJ Open.

How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?

M. Davies, A. Boulle, M. Osler, 2019, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Virologic non‐suppression and early loss to follow up among pregnant and non‐pregnant adolescents aged 15–19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study

C. Yiannoutsos, F. Tanser, A. Haas, 2022, Journal of the International AIDS Society.

Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006–2017

M. Egger, F. Tanser, B. Eley, 2019, The Pediatric infectious disease journal.

Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model

N. Ford, M. Davies, A. Boulle, 2022, AIDS.

Task Shifting for the Delivery of Pediatric Antiretroviral Treatment: A Systematic Review

N. Ford, T. Apollo, M. Davies, 2014, Journal of acquired immune deficiency syndromes.

Adolescent transition among young people with perinatal HIV in high-income and low-income settings

M. Davies, A. Judd, 2018, Current opinion in HIV and AIDS.

Living and dying to be counted: What we know about the epidemiology of the global adolescent HIV epidemic

M. Davies, M. Mahy, A. Slogrove, 2017, Journal of the International AIDS Society.

Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10–14 years) in South Africa

C. Yiannoutsos, F. Tanser, B. Eley, 2021, AIDS.

Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation

M. Egger, M. Davies, N. Anderegg, 2018, Journal of the International AIDS Society.

Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs

Richard D Moore, K. Anastos, O. Kirk, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.

M. Zwahlen, M. Egger, B. Eley, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The future role of CD4 cell count for monitoring antiretroviral therapy.

N. Ford, P. Phanuphak, A. Calmy, 2015, The Lancet. Infectious diseases.

Retention and mortality on antiretroviral therapy in sub‐Saharan Africa: collaborative analyses of HIV treatment programmes

Matthias Egger, Andrew Edmonds, François Dabis, 2018, Journal of the International AIDS Society.

Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa

L. Morris, M. Mendelson, G. Maartens, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

COVID-19 and Pediatric Lung Disease: A South African Tertiary Center Experience

H. Zar, M. Levin, M. Davies, 2021, Frontiers in Pediatrics.

Detection of a SARS-CoV-2 variant of concern in South Africa

A. Godzik, A. Sigal, B. Sewell, 2021, Nature.

COVID-19 wave 4 in Western Cape Province, South Africa: Fewer hospitalisations, but new challenges for a depleted workforce.

M. Davies, A. Boulle, M. Paleker, 2022, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Getting to 90-90-90 in paediatric HIV: What is needed?

M. Davies, J. Pinto, Marlène Bras, 2015, Journal of the International AIDS Society.

Growth in Virologically Suppressed HIV-Positive Children on Antiretroviral Therapy: Individual and Population-level References

M. Egger, B. Eley, A. Grimwood, 2015, The Pediatric infectious disease journal.

Timing of combination antiretroviral therapy (cART) initiation is not associated with stillbirth among HIV‐infected pregnant women in Malawi

A. Jahn, O. Keiser, M. Davies, 2019, Tropical medicine & international health : TM & IH.

Variability of Growth in Children Starting Antiretroviral Treatment in Southern Africa

M. Egger, B. Eley, O. Keiser, 2012, Pediatrics.

First-line antiretroviral drug discontinuations in children

E. Igumbor, G. Maartens, M. Davies, 2017, PloS one.

Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.

M. Egger, B. Eley, R. Wood, 2009, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation

P. Musoke, G. Siberry, M. Davies, 2017, Journal of the International AIDS Society.

Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts

E. Igumbor, G. Maartens, M. Davies, 2018, PloS one.

Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration

M. Yotebieng, S. Ayaya, M. Davies, 2019, Journal of the International AIDS Society.

Incidence of AIDS-defining and Other Cancers in HIV-positive Children in South Africa: Record Linkage Study

M. Egger, B. Eley, J. Bohlius, 2016, The Pediatric infectious disease journal.

Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004–2012

F. Tanser, B. Eley, R. Wood, 2015, Journal of acquired immune deficiency syndromes.

Short-term treatment outcomes of children starting antiretroviral therapy in the intensive care unit, general medical wards and outpatient HIV clinics at Red Cross War Memorial Children's Hospital, Cape Town, South Africa: A retrospective cohort study.

V. Pillay, B. Eley, M. Davies, 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study

Christine S. Smedley, L. Zühlke, S. Naidoo, 2021, The Lancet HIV.

Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis

M. Egger, G. Wandeler, N. Bender, 2012, AIDS.

Missed Opportunities to Prevent Mother-to-Child-Transmission in sub-Saharan Africa: Systematic Review and Meta-Analysis

M. Egger, G. Wandeler, O. Keiser, 2022 .

Overview of SARS-CoV-2 infection in adults living with HIV

Á. Soriano, J. Miro, J. Mallolas, 2021, The Lancet HIV.

Cotrimoxazole prophylactic treatment prevents malaria in children in sub‐Saharan Africa: systematic review and meta‐analysis

M. Egger, G. Wandeler, M. Davies, 2014, Tropical medicine & international health : TM & IH.

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

T. Ndung’u, A. Sigal, B. Sewell, 2021, Nature.

Reversion and conversion of Mycobacterium tuberculosis IFN-γ ELISpot results during anti-tuberculous treatment in HIV-infected children

H. Zar, S. Pienaar, R. Wilkinson, 2010, BMC infectious diseases.

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

T. Ndung’u, A. Sigal, M. Davenport, 2021, Nature.

Mental Health, ART Adherence, and Viral Suppression Among Adolescents and Adults Living with HIV in South Africa: A Cohort Study

G. Maartens, L. Salazar-Vizcaya, A. Haas, 2023, AIDS and Behavior.

Access to antiretroviral therapy in HIV-infected children aged 0–19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004–2015: A prospective cohort study

C. Yiannoutsos, M. Yotebieng, K. Wools-Kaloustian, 2018, PLoS medicine.

Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.

B. Eley, G. Hussey, M. Davies, 2004, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Ongoing High Prevalence of Severe Immune Suppression Among Children in South Africa

N. Ford, M. Davies, G. Patten, 2022, Journal of acquired immune deficiency syndromes.

Survival of HIV-1 vertically infected children

D. Gibb, M. Davies, A. Turkova, 2016, Current opinion in HIV and AIDS.

Virologic Response in Children Treated With Abacavir-compared With Stavudine-based Antiretroviral Treatment: A South African Multi-Cohort Analysis

B. Eley, R. Wood, L. Kuhn, 2014, The Pediatric infectious disease journal.

Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium

T. Puthanakit, K. Wools-Kaloustian, B. Musick, 2020, Journal of the International AIDS Society.

Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.

M. Yotebieng, C. Giaquinto, L. Mofenson, 2019, The lancet. HIV.

Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort

C. Yiannoutsos, M. Yotebieng, S. Ayaya, 2018, Journal of acquired immune deficiency syndromes.

Authors' Reply: Early Initiation of Antiretroviral Therapy Among Young Children: A Long Way to Go.

B. Chi, M. Egger, K. Wools-Kaloustian, 2015, Journal of acquired immune deficiency syndromes.

Effect of antiretroviral therapy care interruptions on mortality in children living with HIV

F. Tanser, B. Eley, M. Vinikoor, 2022, AIDS.

Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study.

M. Yotebieng, M. Vinikoor, M. Davies, 2021, The lancet. HIV.

Using Observational Data to Inform HIV Policy Change for Children and Youth

L. Mofenson, L. Bekker, A. Sohn, 2018, Journal of acquired immune deficiency syndromes.

High Unreported Mortality in Children and Youth (<25 Years) Living With HIV Who Were Lost to Care From Antiretroviral Therapy Programs in Southern Africa: Results From a Multicountry Tracing Study

C. Yiannoutsos, M. Egger, M. Vinikoor, 2022, Journal of acquired immune deficiency syndromes.

Global HIV mortality trends among children on antiretroviral treatment corrected for under‐reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration

C. Yiannoutsos, R. Kassanjee, M. Davies, 2021, Journal of the International AIDS Society.

Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis.

N. Ford, E. Mills, A. Calmy, 2015, The lancet. HIV.

Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High-Income Countries

B. Chi, M. Egger, K. Wools-Kaloustian, 2015, Journal of acquired immune deficiency syndromes.

Prognosis of Children With HIV-1 Infection Starting Antiretroviral Therapy in Southern Africa: A Collaborative Analysis of Treatment Programs

M. Egger, B. Eley, R. Wood, 2014, The Pediatric infectious disease journal.

When to Start Antiretroviral Therapy in Children Aged 2–5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern Africa

M. Egger, L. Muhe, B. Eley, 2013, PLoS medicine.

Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old.

M. Egger, L. Muhe, M. Davies, 2013, The Cochrane database of systematic reviews.

Provider-Initiated HIV Testing and Counselling for Children

M. Davies, E. Kalk, 2014, PLoS medicine.

Acceptability and performance of a directly assisted oral HIV self-testing intervention in adolescents in rural Mozambique

M. Davies, L. Jefferys, M. Hobbins, 2018, PloS one.

Models of support for disclosure of HIV status to HIV‐infected children and adolescents in resource‐limited settings

S. Ayaya, C. Chimbetete, M. Davies, 2018, Journal of the International AIDS Society.

Lamivudine monotherapy as a holding regimen for HIV-positive children

B. Eley, M. Davies, H. Rabie, 2018, PloS one.

Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission

F. Tanser, B. Eley, R. Wood, 2020, PloS one.

What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy ? A Comparison of 4 ART Management Strategies

M. Egger, F. Tanser, B. Eley, 2022 .

Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10-14 Years of Age.

A. Sohn, V. Rouzier, R. Succi, 2021, The Pediatric Infectious Disease Journal.

Research priorities to inform “Treat All” policy implementation for people living with HIV in sub‐Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA)

Rose S. Bono, C. Yiannoutsos, M. Yotebieng, 2019, Journal of the International AIDS Society.

Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997–2021: A cohort study

M. Yotebieng, K. Wools-Kaloustian, B. Musick, 2022, PLoS Medicine.

Impact of universal antiretroviral treatment eligibility on rapid treatment initiation among young adolescents with HIV in sub-Saharan Africa.

K. Wools-Kaloustian, D. Nash, G. Nakigozi, 2020, The Journal of infectious diseases.

Getting to 90-90-90 in paediatric HIV: What is needed?

M. Davies, J. Pinto, Marlène Bras, 2015, Journal of the International AIDS Society.

Hospitalization among infants who initiate antiretroviral therapy before 3 months of age

B. Eley, M. Davies, H. Rabie, 2022, AIDS.

The impact of delayed switch to second-line antiretroviral therapy on mortality, depending on failure time definition and CD4 count at failure

F. Tanser, R. Wood, M. Davies, 2019, bioRxiv.

Diagnosis and treatment of opioid use disorder in a South African private sector medical insurance scheme: a cohort study

M. Egger, G. Maartens, A. Haas, 2022, medRxiv.

The treatment gap for mental disorders in adults enrolled in HIV treatment programmes in South Africa: a cohort study using linked electronic health records

S. Seedat, G. Maartens, C. Lund, 2020, Epidemiology and Psychiatric Sciences.

Mental health, substance use and viral suppression in adolescents receiving ART at a paediatric HIV clinic in South Africa

M. Egger, A. Haas, M. Davies, 2020, Journal of the International AIDS Society.

Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression

N. Ford, L. Mofenson, F. Tanser, 2015, The Pediatric infectious disease journal.

Improving estimates of children living with HIV from the Spectrum AIDS Impact Model

L. Mofenson, A. Ciaranello, M. Davies, 2016, AIDS.

Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium

C. Yiannoutsos, M. Yotebieng, B. Musick, 2020, BMC Research Notes.

Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels

C. Yiannoutsos, R. Glaubius, L. Mofenson, 2019, AIDS.

Temporal Trends in Co-trimoxazole Use Among Children on Antiretroviral Therapy and the Impact of Co-trimoxazole on Mortality Rates in Children Without Severe Immunodeficiency.

M. Yotebieng, K. Wools-Kaloustian, M. Law, 2018, Journal of the Pediatric Infectious Diseases Society.

Current Opinion in HIV and AIDS

J. Bohlius, M. Davies, G. Naidu, 2016 .

Authors' reply: immunodeficiency at the start of combination antiretroviral therapy: steady improvement or step changes?

M. Egger, M. Davies, Manuel Koller, 2015, Journal of acquired immune deficiency syndromes.

HIV transmission and retention in care among HIV-exposed children enrolled in Malawi’s prevention of mother-to-child transmission programme

M. Zwahlen, M. Egger, A. Jahn, 2017, Journal of the International AIDS Society.

Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa.

B. Eley, A. Sohn, C. Chimbetete, 2020, AIDS.

Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis

M. Yotebieng, C. Giaquinto, L. Mofenson, 2022, Journal of the International AIDS Society.

Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children aged 1–5 Years: A Causal Modelling Analysis

M. Egger, F. Tanser, R. Wood, 2017 .

Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes

M. Vinikoor, R. Wood, G. Wandeler, 2017, Journal of acquired immune deficiency syndromes.

HIV drug resistance in sub-Saharan Africa: public health questions and the potential role of real-world data and mathematical modelling

M. Egger, R. Kouyos, G. Wandeler, 2018, Journal of virus eradication.

Poor Early Virologic Performance and Durability of Abacavir-based First-line Regimens for HIV-infected Children

L. Kuhn, M. Davies, E. Abrams, 2013, The Pediatric infectious disease journal.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Clinical Mentorship of Nurse Initiated Antiretroviral Therapy in Khayelitsha, South Africa: A Quality of Care Assessment

M. Davies, G. Patten, V. Cox, 2014, PloS one.

Opportunities during COVID-19 towards achieving Universal Health Coverage

M. Chopra, M. Davies, K. Vallabhjee, 2021, Journal of global health.

Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium

C. Yiannoutsos, M. Yotebieng, B. Musick, 2020, BMC Research Notes.

Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries

B. Chi, J. Sterne, K. Anastos, 2013, Journal of acquired immune deficiency syndromes.

Age-specific mortality rate ratios in adolescents and youth aged 10–24 years living with perinatally versus nonperinatally acquired HIV

K. Wools-Kaloustian, B. Musick, A. Ciaranello, 2020, AIDS.

Brief Report: Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium

M. Yotebieng, L. Mofenson, K. Wools-Kaloustian, 2017, Journal of acquired immune deficiency syndromes.

Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices.

M. Egger, S. Ayaya, L. Mofenson, 2015, Journal of the Pediatric Infectious Diseases Society.

Weight gain of HIV-exposed, uninfected children born before and after introduction of the ‘Option B+’ programme in Malawi

F. Chimbwandira, A. Spoerri, A. Haas, 2018, AIDS.

Kaposi's Sarcoma in HIV‐infected patients in South Africa: Multicohort study in the antiretroviral therapy era

M. Egger, J. Bohlius, M. Davies, 2014, International journal of cancer.

HHV‐8 seroprevalence in HIV‐positive and HIV‐negative populations

M. Egger, J. Bohlius, M. Davies, 2015, International journal of cancer.

Is it safe to drop CD4+ monitoring among virologically suppressed patients: a cohort evaluation from Khayelitsha, South Africa.

N. Ford, M. Davies, A. Boulle, 2014, AIDS.

HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens

A. Godzik, W. Fischer, A. Sigal, 2021, Cell Host & Microbe.

Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study

E. Igumbor, G. Maartens, M. Davies, 2017, Journal of the International AIDS Society.

Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis

N. Ford, M. Davies, G. Meintjes, 2022, The lancet. HIV.

Changes in rapid HIV treatment initiation after national “treat all” policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis

N. Ford, C. Yiannoutsos, K. Wools-Kaloustian, 2019, PLoS medicine.

CD4+ T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa

Richard D Moore, E. Vittinghoff, C. Yiannoutsos, 2015 .

Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization

L. Abu-Raddad, D. Feikin, N. Andrews, 2022, Vaccine.

COVID-19 among adults living with HIV: Correlates of mortality in a general population in a resource-limited setting

M. Mendelson, N. Tiffin, Olina Ngwenya, 2022, medRxiv.

Higher COVID-19 mortality in low-income communities in the City of Cape Town – a descriptive ecological study

L. London, M. Davies, A. Boulle, 2021, Gates open research.

Age-specific and sex-specific weight gain norms to monitor antiretroviral therapy in children in low-income and middle-income countries

M. Yotebieng, F. Behets, O. Keiser, 2015, AIDS.

Medication Side Effects and Retention in HIV Treatment: A Regression Discontinuity Study of Tenofovir Implementation in South Africa and Zambia

T. Bärnighausen, F. Tanser, R. Wood, 2018, American journal of epidemiology.

HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies

M. Zwahlen, M. Egger, H. Furrer, 2017, Journal of the International AIDS Society.

Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis

Thomas Gsponer, Gilles Wandeler, Matthias Egger, 2012, AIDS.

Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi)

J. Etard, M. Davies, E. Goemaere, 2019, Global health action.

The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital

P. Nyasulu, M. Davies, A. Zemlin, 2023, BMC Infectious Diseases.

Hypertensive disorders of pregnancy and HIV: analysis of a province-wide cohort during 2018 and 2019

G. Theron, M. Cotton, M. Davies, 2023, AIDS.

The effect of the COVID-19 lockdown on mental health care use in South Africa: an interrupted time-series analysis

M. Egger, S. Seedat, G. Maartens, 2022, Epidemiology and Psychiatric Sciences.

Mental health, substance use and viral load suppression in adolescents receiving ART at a large paediatric HIV clinic in South Africa

M. Egger, A. Haas, M. Davies, 2020, medRxiv.

Asymptomatic COVID-19 in South Africa - implications for the control of transmission.

S. Madhi, M. Davies, K. McCarthy, 2021, Public health action.

Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa

M. Mendelson, R. Wilkinson, H. Mahomed, 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Twelve-year mortality in adults initiating antiretroviral therapy in South Africa

M. Egger, F. Tanser, R. Wood, 2017, Journal of the International AIDS Society.

Characterizing the double‐sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern Africa

A. Sohn, C. Chimbetete, M. Davies, 2020, Journal of the International AIDS Society.

COVID‐19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa

M. Mendelson, N. Tiffin, Olina Ngwenya, 2023, Journal of the International AIDS Society.

Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa

N. Tiffin, M. Davies, J. Dave, 2021, Diabetes Research and Clinical Practice.

diabetes : A virtual cohort study from theWestern Cape Province , South Africa

N. Tiffin, M. Davies, A. Boulle, 2021 .

Using longitudinal targeted maximum likelihood estimation in complex settings with dynamic interventions

M Schomaker, M A Luque-Fernandez, V Leroy, 2018, Statistics in medicine.

A longitudinal analysis of the completeness of maternal HIV testing, including repeat testing in Cape Town, South Africa

M. Davies, A. Boulle, M. Osler, 2020, Journal of the International AIDS Society.

Evaluation of a public COVID-19 dashboard in the Western Cape, South Africa: a tool for communication, trust, and transparency

M. Davies, A. Boulle, M. Paleker, 2022, BMC Public Health.

The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review

K. Schwartzman, J. Campbell, F. Ahmad Khan, 2023, PLOS global public health.

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.

G. Gottlieb, J. Stringer, C. Yiannoutsos, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Getting to 90-90-90 in paediatric HIV: What is needed?

M. Davies, J. Pinto, H. Rabie, 2015, Journal of the International AIDS Society.

Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children.

L. Mofenson, M. Davies, E. Abrams, 2021, Clinical Infectious Diseases.

Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey

Victor C. M. Leung, L. C. Medina, David J. Smith, 2019, Journal of the International AIDS Society.

Safety and Effectiveness of Isoniazid Preventive Therapy in HIV-Positive Pregnant Women on Art: An Observational Study using Linked Population Data.

L. Myer, G. Maartens, M. Davies, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study

B. Eley, M. Davies, A. Boulle, 2008 .

The interface between SARS-CoV-2 and non-communicable diseases (NCDs) in a high HIV/TB burden district level hospital setting, Cape Town, South Africa

P. Nyasulu, M. Davies, J. L. Tamuzi, 2022, medRxiv.